These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 31111297
21. Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa. Gichane MW, Katz AWK, Ngure K, Scheckter R, Woeber K, Reddy K, Tauya T, Zimba C, Etima J, Mangxilana N, Palanee-Phillips T, van der Straten A, MTN-025/HOPE Study Team. AIDS Behav; 2021 Dec; 25(12):3847-3857. PubMed ID: 34009480 [Abstract] [Full Text] [Related]
22. "The state of mind tells me it's dirty": menstrual shame amongst women using a vaginal ring in Sub Saharan Africa. Duby Z, Katz A, Musara P, Nabukeera J, Zimba CC, Woeber K, Palanee-Phillips T, van der Straten A. Women Health; 2020 Jan; 60(1):72-86. PubMed ID: 31043134 [Abstract] [Full Text] [Related]
26. Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial. Etima J, Katz AWK, Duby Z, Garcia M, Palanee-Phillips T, Reddy K, Mathebula F, Zimba C, Mansoor LE, Singh D, Manengamambo E, Naidoo S, Soto-Torres L, Montgomery ET, MTN-020/ASPIRE, MTN 025/HOPE, MTN-032 Study teams. AIDS Behav; 2022 May; 26(5):1597-1606. PubMed ID: 34727272 [Abstract] [Full Text] [Related]
30. Male Partner Opinions of the Dapivirine Vaginal Ring Used During an Open-Label Extension HIV Prevention Trial in KwaZulu-Natal, South Africa. Morar NS, Mansoor LE, Naidoo K, Katz AWK, Garcia M, Duma C, Precious Myeni NB, Tshbalala T, Naidoo S, Montgomery ET. J Acquir Immune Defic Syndr; 2023 Feb 01; 92(2):127-133. PubMed ID: 36302179 [Abstract] [Full Text] [Related]
32. Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study. Montgomery ET, Roberts ST, Reddy K, Tolley E, Hartmann M, Wilson E, Mathebula F, Wagner LD, Zissette S, Lanham M, Wilcher R, Baeten JM, Palanee-Phillips T. AIDS Behav; 2022 Mar 01; 26(3):752-763. PubMed ID: 34546473 [Abstract] [Full Text] [Related]
35. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness. Glaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW, Parikh UM, Abbas UL. J Int AIDS Soc; 2019 May 01; 22(5):e25282. PubMed ID: 31074936 [Abstract] [Full Text] [Related]
36. Expanding the relationship context for couple-based HIV prevention: Elucidating women's perspectives on non-traditional sexual partnerships. Crankshaw TL, Voce A, Butler LM, Darbes L. Soc Sci Med; 2016 Oct 01; 166():169-176. PubMed ID: 27566046 [Abstract] [Full Text] [Related]
40. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial. Hoffman S, Morrow KM, Mantell JE, Rosen RK, Carballo-Diéguez A, Gai F. Arch Sex Behav; 2010 Jun 01; 39(3):748-60. PubMed ID: 19636696 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]